ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2016, Vol. 25 ›› Issue (2): 119-123.

• 论文 • 上一篇    下一篇

异基因造血干细胞移植后患者急性肾损伤的危险因素及预后分析

  

  • 出版日期:2016-04-28 发布日期:2016-05-04

Acute Kidney Injury in post Allogeneic Hematopoietic Stem Cell Transplantation

  • Online:2016-04-28 Published:2016-05-04

摘要:

【摘要】 目的:分析异基因造血干细胞移植术(HSCT)后急性肾损伤(AKI)患者的临床资料、危险因素及预后,以提高HSCT患者AKI的早期诊疗水平,改善HSCT患者的预后。 方法:回顾性分析2010年1月-2012年12月于苏州大学附属第一医院血液科行HSCT的407例患者移植前与移植后100天内肾功能改变情况,移植预处理方案及并发症,并随访观察1年。按AKI网络标准分为无AKI组和AKI组,并进行分期,通过spearman相关性分析及logistic回归分析筛选出AKI的危险因素。结果:407例患者中,无肾损伤(NAKI组)323例,发生AKI的84例(20.6%),其中AKI I期59例,AKI II期10例,AKI III期15例。Logistic回归分析结果显示:人类白细胞抗原(HLA)不完全匹配、清髓性预处理、移植后并发症(败血症、肝静脉闭塞综合征)是HSCT后患者并发AKI的危险因素(P<0.05);1年后,107例(26.3%)HSCT患者死亡,其中,NAKI患者64例,AKI I期患者26例,AKI II期患者6例,AKI III期患者11例,且死亡率随着AKI的严重程度逐渐增加。结论:AKI是HSCT后的一种常见并发症,发生率为20.6%, HLA不完全匹配、清髓性预处理方式、移植后并发症(败血症、肝静脉闭塞综合征)是HSCT后患者发生AKI的危险因素。HSCT后并发AKI的患者死亡率显著高于NAKI患者,且1年的死亡率随着AKI的严重程度逐渐增加。 

关键词: 造血干细胞移植, 急性肾损伤, 危险因素, 预后

Abstract:

【Abstract】Objective: To analyze the clinical data, risk factors and prognosis of allogeneic hematopoietic stem cell transplantation (HSCT) patients who developed acute kidney injury (AKI) in order to assist the early diagnosis and treatment of AKI patients and improve the prognosis. Methodology: The clinical data of 407 patients who received HSCT from January 2010 to December 2012 in the first affiliated hospital of Soochow University were retrospectively collected. According to the criteria of AKI network (AKIN), these patients were divided into non AKI (NAKI) group and AKI group (stage I-risk, stage II-injury and stage III- renal failure). The changes of renal function before and 100 days after HSGT, the pre-conditioning methods, and the post-transplantation complications were investigated. Each patient was followed up for one year. Spearman test and logistic regression analysis were applied for statistical analysis. Results: They were 323 cases (79.4%) of NAKI, and 84 cases (20.6%) of AKI including 59 at stage I, 10 at stage II and 15 cases at stage III. Logistic regression analysis revealed incomplete human leukocyte antigen (HLA)-match, myeloablative pre-conditioning and post-transplantation complications (sepsis or hepatic vein occlusion syndrome) as the risk factors of AKI (P<0.05). 107 patients (26.3%) including 64 patients in NAKI group, 26 patients at AKI stage I, 6 patients at AKI stage II and 11 patients at AKI stage III died one year after HSCT. The one-year mortality of HSCT patients with AKI gradually increased with the severity of AKI. Conclusion: We demonstrated that AKI was a common complication post HSCT, and incomplete HLA match, myeloablative pre-conditioning or post-HSCT complications (sepsis and hepatic venular occlusive disease) were risk factors of AKI in HSCT patients. The mortality of HSCT patients with AKI was significantly higher than that in NAKI patients, and it increased with the severity of AKI.

Key words: hematopoietic stem cell transplantation (HSCT), acute kidney injury (AKI), risk factors, prognosis